Manulife (Manufacturers Life Insurance)’s Stoke Therapeutics STOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$171K Buy
15,099
+1,862
+14% +$21.1K ﹤0.01% 2616
2025
Q1
$88K Sell
13,237
-67
-0.5% -$446 ﹤0.01% 2728
2024
Q4
$147K Sell
13,304
-314
-2% -$3.46K ﹤0.01% 2726
2024
Q3
$167K Sell
13,618
-346
-2% -$4.25K ﹤0.01% 2727
2024
Q2
$189K Buy
13,964
+1,994
+17% +$26.9K ﹤0.01% 2627
2024
Q1
$162K Buy
11,970
+54
+0.5% +$729 ﹤0.01% 2669
2023
Q4
$62.7K Hold
11,916
﹤0.01% 2903
2023
Q3
$46.9K Sell
11,916
-35,355
-75% -$139K ﹤0.01% 2944
2023
Q2
$502K Buy
47,271
+2,119
+5% +$22.5K ﹤0.01% 2033
2023
Q1
$376K Hold
45,152
﹤0.01% 2183
2022
Q4
$410K Sell
45,152
-33
-0.1% -$300 ﹤0.01% 2115
2022
Q3
$587K Sell
45,185
-344
-0.8% -$4.47K ﹤0.01% 1873
2022
Q2
$603K Buy
45,529
+11,030
+32% +$146K ﹤0.01% 1917
2022
Q1
$755K Buy
34,499
+23,598
+216% +$517K ﹤0.01% 1919
2021
Q4
$262 Buy
10,901
+218
+2% +$5 ﹤0.01% 2712
2021
Q3
$272K Sell
10,683
-757
-7% -$19.3K ﹤0.01% 2751
2021
Q2
$385K Buy
11,440
+3,244
+40% +$109K ﹤0.01% 2615
2021
Q1
$318K Buy
8,196
+300
+4% +$11.6K ﹤0.01% 2577
2020
Q4
$489K Buy
7,896
+276
+4% +$17.1K ﹤0.01% 2208
2020
Q3
$255K Buy
+7,620
New +$255K ﹤0.01% 2410
2020
Q2
Sell
-10,603
Closed -$243K 2922
2020
Q1
$243K Buy
+10,603
New +$243K ﹤0.01% 2209